Drug Trial Radar · NCT02922699
Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
Last checked: Nov 20, 2026Latest source record: Oct 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Jan 2013
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Dr. Reddy's Laboratories Limited, IndiaIndustry
- Sponsor type
- Industry
- First posted
- Oct 4, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Comparison of efficacy of H.pylori eradication during first line therapy using standard or high doses of omeprazole administered twice daily in combination with amoxicillin and clarithromycin for 10 days.
Conditions
- GERD
Interventions
OMEZ 40Drug
Omez 40 given to patients for 58days along with Amoxicilin and Clarithromycin
OMEZ 80Drug
Omez 80 patients for 58days along with Amoxicilin and Clarithromycin
Primary outcomes
What the sponsor says the trial is designed to measure.
- H Pylori eradicaion ratesTime frame: Baseline to 6 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.